La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Paranovus Entertainment Technology Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Paranovus Entertainment Technology ha un patrimonio netto totale di $5.2M e un debito totale di $2.3M, che porta il suo rapporto debito/patrimonio netto a 44.3%. Le sue attività totali e le sue passività totali sono rispettivamente $7.7M e $2.6M.

Informazioni chiave

44.3%

Rapporto debito/patrimonio netto

US$2.29m

Debito

Indice di copertura degli interessi	n/a
Contanti	US$944.24k
Patrimonio netto	US$5.17m
Totale passività	US$2.56m
Totale attività	US$7.73m

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Take Care Before Jumping Onto Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) Even Though It's 26% Cheaper

Mar 20

Here's What To Make Of Happiness Biotech Group's (NASDAQ:HAPP) Returns On Capital

Jan 24

Happiness Biotech stock surge as its e-commerce business grew over 70% M/M in December

Jan 11

Happiness Biotech rallies on subsidiary receiving policy granting 80% tax rebates from local government

Dec 16

Would Shareholders Who Purchased Happiness Biotech Group's (NASDAQ:HAPP) Stock Year Be Happy With The Share price Today?

Nov 24

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( $2.9M ) di PAVS superano le sue passività a breve termine ( $2.6M ).

Passività a lungo termine: PAVS non ha passività a lungo termine.

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 26% ) di PAVS è considerato soddisfacente.

Riduzione del debito: Il rapporto debito/patrimonio netto di PAVS è aumentato da 1.7% a 44.3% negli ultimi 5 anni.

Bilancio

Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: PAVS ha meno di un anno di cash runway in base al suo attuale free cash flow.

Previsione Cash Runway: PAVS ha meno di un anno di liquidità disponibile se il flusso di cassa libero continua a ridursi ai tassi storici del 53.1 % ogni anno

Paranovus Entertainment Technology Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Paranovus Entertainment Technology Ltd. announced delayed 20-F filing

Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

Happiness Development Group Limited announced delayed 20-F filing

Happiness Development Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

Recent updates

Paranovus Entertainment Technology Ltd. announced delayed 20-F filing

New minor risk - Financial data availability

High number of new and inexperienced directors

High number of new and inexperienced directors

New major risk - Market cap size

Take Care Before Jumping Onto Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS) Even Though It's 26% Cheaper

First half 2024 earnings released: EPS: US$2.06 (vs US$0.053 loss in 1H 2023)

Sentiment Still Eluding Paranovus Entertainment Technology Ltd. (NASDAQ:PAVS)

Paranovus Entertainment Technology Ltd. (NasdaqCM:PAVS) entered into a non-binding letter of intent to acquire 100% of Blueline Studios Inc. from Caravan Digital L.P.

Paranovus Entertainment Technology Ltd. (NasdaqCM:PAVS) entered into a non-binding letter of intent to acquire 100% of Blueline Studios Inc. from Caravan Digital L.P.

Full year 2023 earnings released: US$253 loss per share (vs US$24.30 loss in FY 2022)

New major risk - Share price stability

Paranovus Entertainment Technology Ltd., Annual General Meeting, Jun 30, 2023

First half 2023 earnings released: US$9.57 loss per share (vs US$0.37 loss in 1H 2022)

An unknown buyer agreed to acquire 70% stake in Happy Automobile Service (Nanping) Co., Ltd. from Happy Automobile Service (Nanping) Co., Ltd. for CNY 1.4446 million.

Happiness Development Group Limited Announces Chief Financial Officer Changes

First half 2023 earnings released: US$9.57 loss per share (vs US$0.37 loss in 1H 2022)

Happiness Development Group Limited Announces Board Changes

Happiness Development Group Limited Announces Board and Committee Changes

High number of new directors

Happiness Development Group Limited Regains Compliance with Nasdaq Minimum Bid Price Requirement

Happiness Development Group announces 1-for-20 reverse stock split

Happiness Development Group Limited announced delayed 20-F filing

Happiness Development Granted Extension to Meet Nasdaq Minimum Bid Price Requirement

Less than half of directors are independent

Happiness Development Group Limited announced that it expects to receive $10 million in funding

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Investor sentiment improved over the past week

Happiness Biotech Launches Lucidum Tablets on Douyin Mall

Full year 2021 earnings released: EPS US$0.03 (vs US$0.53 in FY 2020)

Happiness Biotech Group (NASDAQ:HAPP) Could Be Struggling To Allocate Capital

Happiness Biotech inks EV distribution agreement with Geely's subsidiary

A Look At Happiness Biotech Group's (NASDAQ:HAPP) Share Price Returns

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: US$2.40

Happiness Biotech Group Limited Launches Auto Sales Platform "Happy Auto"

First half 2021 earnings released: EPS US$0.13

Here's What To Make Of Happiness Biotech Group's (NASDAQ:HAPP) Returns On Capital

Investor sentiment improved over the past week

New 90-day high: US$2.12

Happiness Biotech stock surge as its e-commerce business grew over 70% M/M in December

Happiness Biotech rallies on subsidiary receiving policy granting 80% tax rebates from local government

Would Shareholders Who Purchased Happiness Biotech Group's (NASDAQ:HAPP) Stock Year Be Happy With The Share price Today?

Happiness Biotech Group Limited Approves Appointment of Wenhui Lin as Director

Happiness Biotech Starts Offering Kingdomway Coenzyme Q10 in Its Experience Stores

New 90-day low: US$1.68

New 90-day low: US$1.93

New 90-day low - US$2.25

New 90-day low - US$2.35

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Analisi della pista di contanti

Scoprire le aziende sane